Afghanistan Cricketer Mohammad Shahzad charged for doping Violation, Suspended by ICC

Dubai: Afghanistan's huge hitting batsman Mohammad Shahzad has tried positive for the restricted substance Clenbuterol and will be suspended, the International Cricket Council (ICC) said Thursday.

The 29-year-old was tested in a test directed at the ICC Academy in Dubai just about three months back and the outcomes were investigated at the WADA-authorize research facility in Salt Lake City.

The test outcomes uncovered that the specimen contained a restricted substance called clenbuterol, a substance that goes under the class of anabolic operators. Anabolic steroids are steroidal androgens that incorporate characteristic androgens like testosterone and additionally engineered substances that are basically related and have comparable impacts to testosterone.

"The ICC today reported that Afghanistan's wicketkeeper-batsman Mohammad Shahzad has been accused of an against doping standard infringement under the ICC Anti-Doping Code," said an announcement from the administering body in Dubai.

"The example broke down at the WADA-authorize research facility in Salt Lake City, was found to contain the nearness of Clenbuterol, a denied substance."

Shahzad, who made his universal presentation in 2010, has played 58 coordinates in each of the ODI and Twenty20 series. ( Live Cricket Score )

He has scored 1,901 keeps running in one-dayers with the best score of 131 not out while crushing 1,779 keeps running in T20 with a high of an undefeated 118.

Shahzad is the fourth most elevated run-producer in T20 internationals, notwithstanding passing Indian hotshot Virat Kohli in the rankings when Afghanistan whitewashed Ireland 3-0 not long ago.

The ICC said that he will be prohibited from April 26 "unless he practices his entitlement to challenge the burden of the temporary suspension before such date".

"The matter will now be managed as per the procedure set down in the code, and until such time as the procedure is settled, the ICC will make no further remark on this matter," included the announcement.